Breaking News Instant updates and real-time market news.

FSLY

Fastly

$84.73 /

+4.13 (+5.12%)

12:45
07/29/20
07/29
12:45
07/29/20
12:45

Fastly Inc call volume above normal and directionally bullish

Bullish option flow detected in Fastly Inc with 19,802 calls trading, 1.0x expected, and implied vol increasing over 2 points to 111.73%. 7/31 weekly 90 calls and 7/31 weekly 85 calls are the most active options, with total volume in those strikes near 7,100 contracts. The Put/Call Ratio is 0.20. Earnings are expected on August 5th.

  • 05

    Aug

  • 21

    May

FSLY Fastly
$84.73 /

+4.13 (+5.12%)

07/17/20 William Blair
William Blair starts Cloudflare at Outperform, says warrants premium
07/10/20
Fly Intel: Top five analyst downgrades
07/10/20 Craig-Hallum
Fastly downgraded to Hold from Buy at Craig-Hallum
07/10/20 BofA
Fastly double-downgraded to Underperform from Buy at BofA

TODAY'S FREE FLY STORIES

Recommendations
Celsius Holdings price target raised to $23.50 from $11.75 at Ladenburg » 07:39
08/07/20
08/07
07:39
08/07/20
07:39
CELH

Celsius Holdings

$20.86 /

+5.25 (+33.63%)

Ladenburg analyst Jeffrey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CELH Celsius Holdings
$20.86 /

+5.25 (+33.63%)

CELH Celsius Holdings
$20.86 /

+5.25 (+33.63%)

08/06/20 Roth Capital
Celsius Holdings price target raised to $25 from $14.50 at Roth Capital
07/28/20 B. Riley FBR
Celsius Holdings price target raised to $17 from $11.50 at B. Riley FBR
06/24/20 Maxim
Celsius Holdings price target raised to $15 from $12 at Maxim
04/30/20 Roth Capital
Celsius Holdings initiated with a Buy at Roth Capital
CELH Celsius Holdings
$20.86 /

+5.25 (+33.63%)

  • 12
    Sep
Earnings
PFSweb sees 2020 consolidated SFE revenue growth 9%-12% » 07:39
08/07/20
08/07
07:39
08/07/20
07:39
PFSW

PFSweb

$9.58 /

-0.065 (-0.67%)

Revenue consensus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFSW PFSweb
$9.58 /

-0.065 (-0.67%)

PFSW PFSweb
$9.58 /

-0.065 (-0.67%)

08/03/20 B. Riley FBR
PFSweb price target raised to $9.50 from $7.50 at B. Riley FBR
05/08/20 Lake Street
PFSweb set to benefit from more direct to consumer sales, says Lake Street
01/06/20 Craig-Hallum
PFSweb upgraded to Buy from Hold at Craig-Hallum
11/12/19 Lake Street
Lake Street upgrades PFSweb to Buy, ups target to $5 from $4
PFSW PFSweb
$9.58 /

-0.065 (-0.67%)

Recommendations
Papa John's price target raised to $115 from $95 at BTIG » 07:38
08/07/20
08/07
07:38
08/07/20
07:38
PZZA

Papa John's

$97.38 /

-1.945 (-1.96%)

BTIG analyst Peter Saleh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$97.38 /

-1.945 (-1.96%)

PZZA Papa John's
$97.38 /

-1.945 (-1.96%)

06:45 Today Credit Suisse
Papa John's price target raised to $110 from $90 at Credit Suisse
07/27/20 Stephens
McDonald's, Domino's among restaurant stocks to own now, says Stephens
07/27/20 Longbow
Papa John's U.S. comps up high-teens percentage in recent weeks, says Longbow
07/01/20
Fly Intel: Top five analyst initiations
PZZA Papa John's
$97.38 /

-1.945 (-1.96%)

PZZA Papa John's
$97.38 /

-1.945 (-1.96%)

PZZA Papa John's
$97.38 /

-1.945 (-1.96%)

Recommendations
BeiGene price target raised to $268 from $232 at Ladenburg » 07:38
08/07/20
08/07
07:38
08/07/20
07:38
BGNE

BeiGene

$224.41 /

-1.59 (-0.70%)

Ladenburg analyst Wangzhi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$224.41 /

-1.59 (-0.70%)

BGNE BeiGene
$224.41 /

-1.59 (-0.70%)

08/06/20 Piper Sandler
BeiGene price target raised to $175 from $165 at Piper Sandler
07/21/20 Baird
Assembly Biosciences HBV deal a positive, says Baird
07/20/20 Piper Sandler
BeiGene inked smart deal with Assembly, says Piper Sandler
07/13/20 Maxim
BeiGene price target raised to $250 from $190 at Maxim
BGNE BeiGene
$224.41 /

-1.59 (-0.70%)

BGNE BeiGene
$224.41 /

-1.59 (-0.70%)

Earnings
PFSweb reports Q2 EPS (5c), consensus 0c » 07:38
08/07/20
08/07
07:38
08/07/20
07:38
PFSW

PFSweb

$9.58 /

-0.065 (-0.67%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFSW PFSweb
$9.58 /

-0.065 (-0.67%)

PFSW PFSweb
$9.58 /

-0.065 (-0.67%)

08/03/20 B. Riley FBR
PFSweb price target raised to $9.50 from $7.50 at B. Riley FBR
05/08/20 Lake Street
PFSweb set to benefit from more direct to consumer sales, says Lake Street
01/06/20 Craig-Hallum
PFSweb upgraded to Buy from Hold at Craig-Hallum
11/12/19 Lake Street
Lake Street upgrades PFSweb to Buy, ups target to $5 from $4
PFSW PFSweb
$9.58 /

-0.065 (-0.67%)

Periodicals
TikTok in talks with at least 3 American companies over acquisition, NYT says » 07:37
08/07/20
08/07
07:37
08/07/20
07:37
MSFT

Microsoft

$216.32 /

+3.37 (+1.58%)

, TCEHY

Tencent

$0.00 /

+ (+0.00%)

TikTok is in talks with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$216.32 /

+3.37 (+1.58%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

MSFT Microsoft
$216.32 /

+3.37 (+1.58%)

08/05/20 Morgan Stanley
Morgan Stanley says TikTok US operations could be 'compelling' fit for Microsoft
08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
TCEHY Tencent
$0.00 /

+ (+0.00%)

08/03/20 Morgan Stanley
Sohu.com named a Research Tactical Idea at Morgan Stanley
07/27/20 Barclays
Tencent price target raised to $75 from $63 at Barclays
07/14/20 Citi
Tencent price target raised to HK$649 from HK$541 at Citi
07/08/20 Mizuho
Tencent price target raised to HK$475 from HK$410 at Mizuho
MSFT Microsoft
$216.32 /

+3.37 (+1.58%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

MSFT Microsoft
$216.32 /

+3.37 (+1.58%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

MSFT Microsoft
$216.32 /

+3.37 (+1.58%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

MSFT Microsoft
$216.32 /

+3.37 (+1.58%)

MSFT Microsoft
$216.32 /

+3.37 (+1.58%)

Hot Stocks
FDA accepts Biogen's aducanumab BLA for Alzheimer's with priority review » 07:37
08/07/20
08/07
07:37
08/07/20
07:37
BIIB

Biogen

$277.44 /

+1.3 (+0.47%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

Biogen (Nasdaq: BIIB) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$277.44 /

+1.3 (+0.47%)

ESALY Eisai
$0.00 /

+ (+0.00%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

08/06/20 Goldman Sachs
Denali's LRRK2 program complementary to Biogen's PD pipeline, says Goldman Sachs
08/06/20 Wells Fargo
Biogen 'doubling down on LRRK2' via deal with Denali, says Wells Fargo
07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Morgan Stanley
Biogen double upgraded to Overweight from Underweight at Morgan Stanley
ESALY Eisai
$0.00 /

+ (+0.00%)

10/24/19 Nomura Instinet
Eisai upgraded to Buy from Neutral at Nomura Instinet
09/24/19 Jefferies
Eisai initiated with a Buy at Jefferies
09/17/19 Daiwa
Eisai downgraded to Sell from Neutral at Daiwa
BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

Upgrade
Solar Senior Capital upgraded to Buy from Neutral at Ladenburg » 07:37
08/07/20
08/07
07:37
08/07/20
07:37
SUNS

Solar Senior Capital

$13.05 /

-0.24 (-1.81%)

Ladenburg analyst Mickey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SUNS Solar Senior Capital
$13.05 /

-0.24 (-1.81%)

SUNS Solar Senior Capital
$13.05 /

-0.24 (-1.81%)

Hot Stocks
Biogen jumps 10% to $305 after FDA accepts aducanumab with priority review  07:36
08/07/20
08/07
07:36
08/07/20
07:36
BIIB

Biogen

$277.44 /

+1.3 (+0.47%)

 
ShowHide Related Items >><<
BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

08/06/20 Goldman Sachs
Denali's LRRK2 program complementary to Biogen's PD pipeline, says Goldman Sachs
08/06/20 Wells Fargo
Biogen 'doubling down on LRRK2' via deal with Denali, says Wells Fargo
07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Morgan Stanley
Biogen double upgraded to Overweight from Underweight at Morgan Stanley
BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

Hot Stocks
Crinetics sees topline data from Edge, Evolve trials in Q4 » 07:36
08/07/20
08/07
07:36
08/07/20
07:36
CRNX

Crinetics

$14.83 /

+0.17 (+1.16%)

Confirmed completion for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRNX Crinetics
$14.83 /

+0.17 (+1.16%)

CRNX Crinetics
$14.83 /

+0.17 (+1.16%)

05/11/20 Cantor Fitzgerald
Crinetics price target raised to $38 from $28 at Cantor Fitzgerald
05/08/20 Piper Sandler
Piper Sandler continues to recommend Crinetics after paltusotine data
04/07/20 Piper Sandler
Crinetics shares 'should be up meaningfully,' says Piper Sandler
12/23/19 Roth Capital
Crinetics initiated with a Buy at Roth Capital
CRNX Crinetics
$14.83 /

+0.17 (+1.16%)

  • 15
    Apr
CRNX Crinetics
$14.83 /

+0.17 (+1.16%)

Upgrade
Solar Capital upgraded to Buy from Neutral at Ladenburg » 07:36
08/07/20
08/07
07:36
08/07/20
07:36
SLRC

Solar Capital

$16.68 /

-0.07 (-0.42%)

Ladenburg Thalmann…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLRC Solar Capital
$16.68 /

-0.07 (-0.42%)

SLRC Solar Capital
$16.68 /

-0.07 (-0.42%)

05/11/20 Deutsche Bank
Solar Capital price target lowered to $18.50 from $23.50 at Deutsche Bank
04/02/20 Compass Point
Solar Capital upgraded to Buy from Neutral at Compass Point
03/25/20 Wells Fargo
Solar Capital upgraded to Overweight from Equal Weight at Wells Fargo
02/24/20 Ladenburg
Solar Capital downgraded to Neutral from Buy at Ladenburg
SLRC Solar Capital
$16.68 /

-0.07 (-0.42%)

Earnings
Crinetics reports Q2 EPS (53c), consensus (57c) » 07:35
08/07/20
08/07
07:35
08/07/20
07:35
CRNX

Crinetics

$14.83 /

+0.17 (+1.16%)

"Crinetics has made…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRNX Crinetics
$14.83 /

+0.17 (+1.16%)

CRNX Crinetics
$14.83 /

+0.17 (+1.16%)

05/11/20 Cantor Fitzgerald
Crinetics price target raised to $38 from $28 at Cantor Fitzgerald
05/08/20 Piper Sandler
Piper Sandler continues to recommend Crinetics after paltusotine data
04/07/20 Piper Sandler
Crinetics shares 'should be up meaningfully,' says Piper Sandler
12/23/19 Roth Capital
Crinetics initiated with a Buy at Roth Capital
CRNX Crinetics
$14.83 /

+0.17 (+1.16%)

  • 15
    Apr
CRNX Crinetics
$14.83 /

+0.17 (+1.16%)

Earnings
Meridian Bioscience sees 2020 adj. EPS $1.01-$1.05, consensus 75c » 07:34
08/07/20
08/07
07:34
08/07/20
07:34
VIVO

Meridian Bioscience

$24.30 /

-2.09 (-7.92%)

Sees revenue $245M-$250M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIVO Meridian Bioscience
$24.30 /

-2.09 (-7.92%)

VIVO Meridian Bioscience
$24.30 /

-2.09 (-7.92%)

07/27/20 H.C. Wainwright
Meridian Bioscience initiated with a Buy at H.C. Wainwright
05/11/20
Fly Intel: Top five analyst upgrades
05/11/20 William Blair
COVID testing drives Blair to upgrade Meridian for first time in 10 years
05/11/20 William Blair
Meridian Bioscience upgraded to Outperform from Market Perform at William Blair
VIVO Meridian Bioscience
$24.30 /

-2.09 (-7.92%)

VIVO Meridian Bioscience
$24.30 /

-2.09 (-7.92%)

Hot Stocks
Biogen's aducanumab assigned PDUFA target action date of March 7, 2021  07:33
08/07/20
08/07
07:33
08/07/20
07:33
BIIB

Biogen

$277.44 /

+1.3 (+0.47%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
BIIB Biogen
$277.44 /

+1.3 (+0.47%)

ESALY Eisai
$0.00 /

+ (+0.00%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

08/06/20 Goldman Sachs
Denali's LRRK2 program complementary to Biogen's PD pipeline, says Goldman Sachs
08/06/20 Wells Fargo
Biogen 'doubling down on LRRK2' via deal with Denali, says Wells Fargo
07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Morgan Stanley
Biogen double upgraded to Overweight from Underweight at Morgan Stanley
ESALY Eisai
$0.00 /

+ (+0.00%)

10/24/19 Nomura Instinet
Eisai upgraded to Buy from Neutral at Nomura Instinet
09/24/19 Jefferies
Eisai initiated with a Buy at Jefferies
09/17/19 Daiwa
Eisai downgraded to Sell from Neutral at Daiwa
BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

Hot Stocks
Biogen reports FDA accepts aducanumab BLA for Alzheimer's with priority review  07:32
08/07/20
08/07
07:32
08/07/20
07:32
BIIB

Biogen

$277.44 /

+1.3 (+0.47%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
BIIB Biogen
$277.44 /

+1.3 (+0.47%)

ESALY Eisai
$0.00 /

+ (+0.00%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

08/06/20 Goldman Sachs
Denali's LRRK2 program complementary to Biogen's PD pipeline, says Goldman Sachs
08/06/20 Wells Fargo
Biogen 'doubling down on LRRK2' via deal with Denali, says Wells Fargo
07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Morgan Stanley
Biogen double upgraded to Overweight from Underweight at Morgan Stanley
ESALY Eisai
$0.00 /

+ (+0.00%)

10/24/19 Nomura Instinet
Eisai upgraded to Buy from Neutral at Nomura Instinet
09/24/19 Jefferies
Eisai initiated with a Buy at Jefferies
09/17/19 Daiwa
Eisai downgraded to Sell from Neutral at Daiwa
BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

BIIB Biogen
$277.44 /

+1.3 (+0.47%)

Earnings
Meridian Bioscience reports Q3 adj. EPS 55c, consensus 23c » 07:32
08/07/20
08/07
07:32
08/07/20
07:32
VIVO

Meridian Bioscience

$24.30 /

-2.09 (-7.92%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIVO Meridian Bioscience
$24.30 /

-2.09 (-7.92%)

VIVO Meridian Bioscience
$24.30 /

-2.09 (-7.92%)

07/27/20 H.C. Wainwright
Meridian Bioscience initiated with a Buy at H.C. Wainwright
05/11/20
Fly Intel: Top five analyst upgrades
05/11/20 William Blair
COVID testing drives Blair to upgrade Meridian for first time in 10 years
05/11/20 William Blair
Meridian Bioscience upgraded to Outperform from Market Perform at William Blair
VIVO Meridian Bioscience
$24.30 /

-2.09 (-7.92%)

VIVO Meridian Bioscience
$24.30 /

-2.09 (-7.92%)

Earnings
Contura Energy reports Q2 EPS ($13.02), consensus ($3.33) » 07:32
08/07/20
08/07
07:32
08/07/20
07:32
CTRA

Contura Energy

$3.59 /

-0.15 (-4.01%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTRA Contura Energy
$3.59 /

-0.15 (-4.01%)

CTRA Contura Energy
$3.59 /

-0.15 (-4.01%)

07/10/20 Benchmark
Contura Energy downgraded to Hold on met coal price challenges at Benchmark
07/10/20 Benchmark
Contura Energy downgraded to Hold from Buy at Benchmark
06/09/20 B. Riley FBR
B. Riley FBR downgrades Contura Energy after liquidity stress test
06/09/20 B. Riley FBR
Contura Energy downgraded to Neutral from Buy at B. Riley FBR
CTRA Contura Energy
$3.59 /

-0.15 (-4.01%)

Hot Stocks
E.W. Scripps suspends issuing new guidance » 07:32
08/07/20
08/07
07:32
08/07/20
07:32
SSP

E.W. Scripps

$11.90 /

+0.45 (+3.93%)

Scripps has suspended…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSP E.W. Scripps
$11.90 /

+0.45 (+3.93%)

SSP E.W. Scripps
$11.90 /

+0.45 (+3.93%)

07/07/20
Stitcher would help Sirius 'future-proof' business, says B. Riley FBR
06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
03/03/20 Wells Fargo
Disney price target lowered to $155 from $180 at Wells Fargo
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle
SSP E.W. Scripps
$11.90 /

+0.45 (+3.93%)

SSP E.W. Scripps
$11.90 /

+0.45 (+3.93%)

SSP E.W. Scripps
$11.90 /

+0.45 (+3.93%)

Earnings
Par Technology reports Q2 EPS (24c), consensus (39c) » 07:31
08/07/20
08/07
07:31
08/07/20
07:31
PAR

Par Technology

$34.91 /

+0.44 (+1.28%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAR Par Technology
$34.91 /

+0.44 (+1.28%)

PAR Par Technology
$34.91 /

+0.44 (+1.28%)

06/22/20 Craig-Hallum
Par Technology price target raised to $40 from $30 at Craig-Hallum
06/18/20 Roth Capital
Par Technology upgraded to Buy at Roth Capital as 'growth is back'
06/18/20 Roth Capital
Par Technology upgraded to Buy from Neutral at Roth Capital
06/15/20 BTIG
Par Technology initiated with a Buy at BTIG
PAR Par Technology
$34.91 /

+0.44 (+1.28%)

PAR Par Technology
$34.91 /

+0.44 (+1.28%)

Earnings
E.W. Scripps reports Q2 cont ops EPS (22c), consensus (36c) » 07:31
08/07/20
08/07
07:31
08/07/20
07:31
SSP

E.W. Scripps

$11.90 /

+0.45 (+3.93%)

Reports Q2 revenue $359M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSP E.W. Scripps
$11.90 /

+0.45 (+3.93%)

SSP E.W. Scripps
$11.90 /

+0.45 (+3.93%)

07/07/20
Stitcher would help Sirius 'future-proof' business, says B. Riley FBR
06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
03/03/20 Wells Fargo
Disney price target lowered to $155 from $180 at Wells Fargo
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle
SSP E.W. Scripps
$11.90 /

+0.45 (+3.93%)

SSP E.W. Scripps
$11.90 /

+0.45 (+3.93%)

SSP E.W. Scripps
$11.90 /

+0.45 (+3.93%)

Earnings
TripAdvisor sees Q3 revenue above Q2 and lower than 3Q19, consensus $181.11M » 07:31
08/07/20
08/07
07:31
08/07/20
07:31
TRIP

TripAdvisor

$21.62 /

+0.52 (+2.46%)

Sees Q3 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIP TripAdvisor
$21.62 /

+0.52 (+2.46%)

TRIP TripAdvisor
$21.62 /

+0.52 (+2.46%)

07/29/20 Jefferies
Booking Holdings price target raised to $1,600 from $1,300 at Jefferies
06/23/20 RBC Capital
TripAdvisor's Q2 update implies sequential improvement, says RBC Capital
06/10/20 BTIG
TripAdvisor initiated with a Neutral at BTIG
05/11/20 Credit Suisse
TripAdvisor price target lowered to $22 from $28 at Credit Suisse
TRIP TripAdvisor
$21.62 /

+0.52 (+2.46%)

TRIP TripAdvisor
$21.62 /

+0.52 (+2.46%)

TRIP TripAdvisor
$21.62 /

+0.52 (+2.46%)

TRIP TripAdvisor
$21.62 /

+0.52 (+2.46%)

Earnings
Ocular Therapeutix reports Q2 EPS (64c), consensus (31c) » 07:30
08/07/20
08/07
07:30
08/07/20
07:30
OCUL

Ocular Therapeutix

$8.47 /

-0.27 (-3.09%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$8.47 /

-0.27 (-3.09%)

OCUL Ocular Therapeutix
$8.47 /

-0.27 (-3.09%)

07/22/20 Piper Sandler
Ocular Therapeutix price target raised to $14 from $11 at Piper Sandler
07/06/20 Piper Sandler
Ocular Therapeutix protocol deviation 'changes little,' says Piper Sandler
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
05/08/20 Piper Sandler
Ocular Therapeutix long-term opportunity intact, says Piper Sandler
OCUL Ocular Therapeutix
$8.47 /

-0.27 (-3.09%)

  • 20
    May
OCUL Ocular Therapeutix
$8.47 /

-0.27 (-3.09%)

Recommendations
Purple Innovation price target raised to $27 from $17 at Wedbush » 07:27
08/07/20
08/07
07:27
08/07/20
07:27
PRPL

Purple Innovation

$24.77 /

+0.095 (+0.39%)

Wedbush analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRPL Purple Innovation
$24.77 /

+0.095 (+0.39%)

PRPL Purple Innovation
$24.77 /

+0.095 (+0.39%)

08/03/20
Fly Intel: Top five analyst initiations
08/03/20 Craig-Hallum
Purple Innovation initiated with a Buy at Craig-Hallum
07/28/20 Oppenheimer
Purple Innovation price target raised to $25 from $19 at Oppenheimer
07/16/20 Wedbush
Sleep Number price target raised to $52 from $30 at Wedbush
PRPL Purple Innovation
$24.77 /

+0.095 (+0.39%)

  • 15
    May
  • 15
    Nov
PRPL Purple Innovation
$24.77 /

+0.095 (+0.39%)

PRPL Purple Innovation
$24.77 /

+0.095 (+0.39%)

Earnings
Surgalign not providing FY20 financial guidance » 07:27
08/07/20
08/07
07:27
08/07/20
07:27
SRGA

Surgalign

$2.89 /

-0.065 (-2.20%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRGA Surgalign
$2.89 /

-0.065 (-2.20%)

SRGA Surgalign
$2.89 /

-0.065 (-2.20%)

SRGA Surgalign
$2.89 /

-0.065 (-2.20%)

Recommendations
Fortinet price target raised to $134 from $122 at UBS » 07:27
08/07/20
08/07
07:27
08/07/20
07:27
FTNT

Fortinet

$139.46 /

-0.68 (-0.49%)

UBS analyst Fatima…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTNT Fortinet
$139.46 /

-0.68 (-0.49%)

FTNT Fortinet
$139.46 /

-0.68 (-0.49%)

07/15/20 OTR Global
Fortinet downgraded to Mixed from Positive at OTR Global
07/15/20 Goldman Sachs
Fortinet downgraded to Neutral from Buy at Goldman Sachs
07/09/20 Citi
Citi recommends overweight Palo Alto Networks, underweight Fortinet pair trade
07/07/20 JPMorgan
Fortinet downgraded to Neutral with $135 target at JPMorgan
FTNT Fortinet
$139.46 /

-0.68 (-0.49%)

FTNT Fortinet
$139.46 /

-0.68 (-0.49%)

FTNT Fortinet
$139.46 /

-0.68 (-0.49%)

FTNT Fortinet
$139.46 /

-0.68 (-0.49%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.